The Prevent Cancer Advocacy Workshop will be held on March 25, 2020, at FHI 360 in Washington, D.C.
March 25, 2020
FHI 360, Washington, DC
The workshop will serve as a forum for patients, providers, advocacy organizations and other stakeholders to engage in a dialogue around issues regarding hereditary conditions, somatic mutations and biomarkers. Attendees will leave with a better understanding of the role these factors play in prevention and early detection and solutions to improve patient awareness and engagement.
The Prevent Cancer Advocacy Workshop is an annual conference that convenes stakeholders to discuss pressing issues that impact cancer prevention and early detection, as well as novel approaches to address these issues through policy and advocacy. The Workshop is an open forum that allows participants to immerse themselves in engaging presentations, facilitated conversations and build capacity for creative solutions through collaboration with other attendees.